The trademark COVAXIN BHARAT BIOTECH was filed by Bharat Biotech International Limited, a corporation established under the laws of the Republic of India (the "Applicant"). The application was published for oppositions on August 21, 2022, and received one opposition filed on November 17, 2022 by Sanofi Pasteur Europe on Likelihood of confusion. the opponent was represented by CASALONGA ALICANTE, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 17, 2022
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).
The Opposition with reference B 003183338 was refused according to Article 8(1)(b) EUTMR with decision issued on December 20, 2023 by the EUIPO.